We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates Purple Book to Include All CBER-, CDER-licensed Biologics
FDA Updates Purple Book to Include All CBER-, CDER-licensed Biologics
The FDA has updated its Purple Book to include all licensed biological products overseen by the Centers for Biologics Evaluation and Research (CBER) and Drug Evaluation and Research (CDER).